Team

Hugo is passionate about discovery, innovation and commercial conversion. He has worked in a diverse range of fields including scientific education (retail), healthcare (delivery), property (enviro-friendly and affordable), hospitality and latterly primary care investigative and diagnostic solutions (ongoing). Hugo is also the original designer of the Oricol™ device.

Ian Daniels is a Consultant Colorectal & General Surgeon based at the Royal Devon & Exeter Hospital. His research interests include the diagnosis and management of bowel cancer, surgery for locally advanced and recurrent bowel cancer. His research portfolio can be viewed on PubMed [Daniels I]. Outside of clinical work he is Honorary President of Colostomy UK and front row for Team Colostomy UK.

Belinda is a Senior Lecturer in Molecular Epidemiology and epigenetics at The Queen Mary University in London. She has a PhD in functional genomics and genetics. In addition to being the CSO of Origin Sciences, she is also working on CRUK sponsored studies looking at early detection of cancer using methylation biomarkers for Cervical, Prostate and Breast cancer. Specialities include genetics, genomics, NGS, cellular and molecular biology, inflammation and cancer.

Megan is an accomplished medical device and pharmaceutical professional, with experience gained through various roles including Technical development, Quality and Regulatory. Megan has worked with reputable organisations in the industry such as GSK, and most recently a small organisation specialising in drug delivery to the lungs, playing a leading role in device certification and development.

Rupert is a chartered accountant, with specialities in structured finance and venture capital. He has spent the last 25 years founding and building businesses in the energy, information, finance, medical and media sectors at a multi-billion pound level. Rupert is a co-founder of Origin Sciences.

Stuart qualified as a Chartered Accountant at KPMG, and subsequently worked in the manufacturing sector – ultimately taking the role of CFO of a fully quoted company, leading 16 global acquisitions, and 4 green field start-ups – often in conjunction with Rupert Lywood (Chairman).

Mr. Jay Luo is the President & Partner of Dymon Asia Capital, a Singapore headquartered alternative asset management firm. Dymon Asia established a strategic partnership with Temasek, a Singapore-based investment company, in 2014. Previously, Jay was the Head of APAC for S.A.C. Capital Advisors.

Chris is a skilled Quality Assurance professional, with experience gained throughout various industries. Originally qualified as a Mechanical Engineer, working in Manufacturing and Design, Chris later moved into the Quality Assurance sector working within the Medical Device industry. Chris has worked within Quality for over 10 years, working with reputable organisations such as Astra Zeneca, Vectura, Oval Medical and many more. Specialities include ISO 13485:2016, ISO 14971:2019 and Creation and Management of Quality Management Systems.

Guy is an diagnostics specialist with 15 years’ experience in the food, dairy water, brewing, veterinary and clinical sectors. He has a PhD in microbiology and is a fellow of the institute of biomedical science. His recent work has focussed on colorectal cancer, designing and launching a suite of precision oncology assays into the NHS, private and international markets. He has founded start-ups in the diagnostic sector focussing on point-of-care testing and data management.